• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原角蛋白和流星样肽在光化性角化病进展为鳞状细胞癌中的作用。

Role of asprosin and meteorin-like peptide in progression of actinic keratosis to squamous cell carcinoma.

机构信息

Department of Dermatology, Biruni University Faculty of Medicine, Istanbul, Turkey.

Department of Dermatology, Firat University School of Medicine, Elazig, Turkey.

出版信息

Biotech Histochem. 2024 Feb;99(2):61-68. doi: 10.1080/10520295.2024.2302016. Epub 2024 Jan 9.

DOI:10.1080/10520295.2024.2302016
PMID:38192243
Abstract

Squamous cell carcinoma (SCC) often develops from an underlying premalignant lesion. Factors that affect the progression of actinic keratosis (AK) to invasive SCC are not fully known. Asprosin (ASP) and meteorin-like peptide (METRNL) are adipokines that are involved primarily in glucose metabolism. We investigated the expression of ASP and METRNL in AK and SCC to evaluate the role of these adipokines in the development of SCC. We used 15 SCC specimens, 12 AK specimens and 12 healthy control skin specimens. ASP and METRNL protein expression in tumor and surrounding tissue was evaluated using immunohistochemistry. ASP expression in tumor tissue was significantly greater in the SCC group than in the control and AK groups, but it did not differ significantly between the AK and control groups. A positive correlation was observed for both ASP and METRNL expressions between tumor tissue and adjacent epidermis, hair follicles, sebaceous gland, eccrine gland, inflammatory cells and vascular structures. ASP and METRNL may exert pro-tumor effects toward development of invasive SCC. The expression intensity of ASP and METRNL can be used as a biomarker of risk of progression to SCC.

摘要

鳞状细胞癌 (SCC) 常由潜在的癌前病变发展而来。影响光化性角化病 (AK) 进展为浸润性 SCC 的因素尚不完全清楚。内脏脂肪素 (ASP) 和类 meteorin 肽 (METRNL) 是主要参与葡萄糖代谢的脂肪因子。我们研究了 AK 和 SCC 中 ASP 和 METRNL 的表达,以评估这些脂肪因子在 SCC 发展中的作用。我们使用了 15 例 SCC 标本、12 例 AK 标本和 12 例健康对照皮肤标本。采用免疫组织化学法检测肿瘤和周围组织中 ASP 和 METRNL 蛋白的表达。结果显示,SCC 组肿瘤组织中 ASP 的表达明显高于对照组和 AK 组,但 AK 组和对照组之间无显著性差异。ASP 和 METRNL 的表达在肿瘤组织与相邻表皮、毛囊、皮脂腺、小汗腺、炎症细胞和血管结构之间呈正相关。ASP 和 METRNL 可能对浸润性 SCC 的发展产生促肿瘤作用。ASP 和 METRNL 的表达强度可作为 SCC 进展风险的生物标志物。

相似文献

1
Role of asprosin and meteorin-like peptide in progression of actinic keratosis to squamous cell carcinoma.原角蛋白和流星样肽在光化性角化病进展为鳞状细胞癌中的作用。
Biotech Histochem. 2024 Feb;99(2):61-68. doi: 10.1080/10520295.2024.2302016. Epub 2024 Jan 9.
2
Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis.zeste同源物2(EZH2)增强子的表达增加可区分鳞状细胞癌与正常皮肤及光化性角化病。
Eur J Dermatol. 2014 Jan-Feb;24(1):41-5. doi: 10.1684/ejd.2013.2219.
3
Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.P27、Ki67和P53在鳞状细胞癌、光化性角化病和鲍温病中的表达。
Pak J Biol Sci. 2009 Jun 15;12(12):929-33. doi: 10.3923/pjbs.2009.929.933.
4
Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.基质金属蛋白酶-2(MMP-2)和膜型基质金属蛋白酶-1(MT1-MMP)在光化性角化病、皮肤鳞状细胞癌和基底细胞癌中的蛋白表达。
Int J Surg Pathol. 2015 Feb;23(1):20-5. doi: 10.1177/1066896914540998. Epub 2014 Jun 30.
5
Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.光化性角化病进展为鳞状细胞癌的再探讨:临床及治疗意义
Cutis. 2011 Apr;87(4):201-7.
6
Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.环氧化酶2、EZH-2多梳蛋白家族和p53在光化性角化病及皮肤鳞状细胞癌中的表达意义
Am J Dermatopathol. 2013 Jun;35(4):425-31. doi: 10.1097/DAD.0b013e318271292a.
7
Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.正常人皮肤、光化性角化病和鳞状细胞癌的基因表达模式:疾病进展的一个谱系
Arch Dermatol. 2010 Mar;146(3):288-93. doi: 10.1001/archdermatol.2009.378.
8
Expression of G1/S-cyclins and cyclin-dependent kinase inhibitors in actinic keratosis and squamous cell carcinoma.G1/S 期细胞周期蛋白及细胞周期蛋白依赖性激酶抑制剂在光化性角化病和鳞状细胞癌中的表达
J Cutan Pathol. 2016 Mar;43(3):200-10. doi: 10.1111/cup.12623. Epub 2015 Oct 19.
9
An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.基底细胞癌、鳞状细胞癌、光化性角化病和脂溢性角化病组织病理学变体中Bcl-2表达的概述。
Coll Antropol. 2008 Oct;32 Suppl 2:61-5.
10
Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis.金属硫蛋白在皮肤鳞状细胞癌和光化性角化病中的表达。
Pathol Oncol Res. 2012 Oct;18(4):849-55. doi: 10.1007/s12253-012-9513-0. Epub 2012 Mar 10.

引用本文的文献

1
The diagnostic potential of Asprosin and Meteorin-like proteins in basal and squamous cell carcinomas.Asprosin和类Meteorin蛋白在基底细胞癌和鳞状细胞癌中的诊断潜力。
Arch Dermatol Res. 2025 Mar 17;317(1):574. doi: 10.1007/s00403-025-04099-w.
2
Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer.肥胖调节癌症炎症和抗肿瘤免疫的机制。
Biochem Biophys Res Commun. 2024 Nov 12;733:150437. doi: 10.1016/j.bbrc.2024.150437. Epub 2024 Jul 23.